11-17356820-A-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001202439.3(NCR3LG1):​c.240A>C​(p.Glu80Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000939 in 1,383,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000094 ( 0 hom. )

Consequence

NCR3LG1
NM_001202439.3 missense

Scores

1
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0950

Publications

0 publications found
Variant links:
Genes affected
NCR3LG1 (HGNC:42400): (natural killer cell cytotoxicity receptor 3 ligand 1) B7H6 belongs to the B7 family (see MIM 605402) and is selectively expressed on tumor cells. Interaction of B7H6 with NKp30 (NCR3; MIM 611550) results in natural killer (NK) cell activation and cytotoxicity (Brandt et al., 2009 [PubMed 19528259]).[supplied by OMIM, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.112766504).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCR3LG1NM_001202439.3 linkc.240A>C p.Glu80Asp missense_variant Exon 2 of 5 ENST00000338965.9 NP_001189368.1 Q68D85
NCR3LG1XM_047426906.1 linkc.240A>C p.Glu80Asp missense_variant Exon 2 of 6 XP_047282862.1
NCR3LG1XM_011520074.4 linkc.153A>C p.Glu51Asp missense_variant Exon 2 of 5 XP_011518376.1
NCR3LG1XM_011520075.4 linkc.153A>C p.Glu51Asp missense_variant Exon 2 of 5 XP_011518377.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCR3LG1ENST00000338965.9 linkc.240A>C p.Glu80Asp missense_variant Exon 2 of 5 1 NM_001202439.3 ENSP00000341637.4 Q68D85
NCR3LG1ENST00000530403.1 linkn.240A>C non_coding_transcript_exon_variant Exon 2 of 6 5 ENSP00000434394.1 Q68D85

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.0000143
AC:
2
AN:
139642
AF XY:
0.0000132
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000190
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000939
AC:
13
AN:
1383832
Hom.:
0
Cov.:
31
AF XY:
0.00000586
AC XY:
4
AN XY:
682858
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31594
American (AMR)
AF:
0.00
AC:
0
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25182
East Asian (EAS)
AF:
0.0000560
AC:
2
AN:
35734
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33902
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5690
European-Non Finnish (NFE)
AF:
0.00000927
AC:
10
AN:
1078878
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 24, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.240A>C (p.E80D) alteration is located in exon 2 (coding exon 2) of the NCR3LG1 gene. This alteration results from a A to C substitution at nucleotide position 240, causing the glutamic acid (E) at amino acid position 80 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.72
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0038
T
Eigen
Benign
-0.85
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.019
N
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.2
L
PhyloP100
0.095
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.75
N
REVEL
Benign
0.084
Sift
Benign
0.36
T
Sift4G
Benign
0.069
T
Polyphen
0.99
D
Vest4
0.21
MutPred
0.38
Loss of ubiquitination at K77 (P = 0.1179);
MVP
0.055
ClinPred
0.060
T
GERP RS
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.22
gMVP
0.49
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1565501467; hg19: chr11-17378367; API